Cholecystokinin-octapeptide restored morphine-induced hippocampal long-term potentiation impairment in rats

Neuroscience Letters

Volumn 559, Issue , 2014, Pages 76-81

  Wen, Di ^a   Zang, Guoqing ^a   Sun, DongLei ^a   Yu, Feng ^a   Mei, Dong ^a   Ma, Chunling ^a   Cong, Bin ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

CCK receptor; Cholecystokinin octapeptide; Hippocampus; Long term potentiation; Morphine

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; DEVAZEPIDE; MORPHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; GRANULE CELL; HIPPOCAMPAL CA1 REGION; LATERAL PERFORANT PATH; LONG TERM POTENTIATION; MALE; MICROINJECTION; NERVE STIMULATION; NONHUMAN; PERFORANT NERVE TRACT; PRIORITY JOURNAL; RAT; SPIKE WAVE;

CCK RECEPTOR; CHOLECYSTOKININ-OCTAPEPTIDE; HIPPOCAMPUS; LONG-TERM POTENTIATION; MORPHINE;

ANIMALS; ELECTRODES, IMPLANTED; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MICROINJECTIONS; MORPHINE; RATS; RATS, WISTAR; SINCALIDE;

EID: 84890841617     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.11.043     Document Type: Article

References (37)

1. Aguilar M.A., Minarro J., Simon V.M. Dose-dependent impairing effects of morphine on avoidance acquisition and performance in male mice. Neurobiol. Learn. Mem. 1998, 69:92-105.
2. Anokhina I.P., Proskuriakova T.V. Involvement of the neuropeptide cholecystokinin in the mechanisms of regulation of emotions and craving. Vestnik Rossiiskoi akademii meditsinskikh nauk 2002, 36-40.
3. Bandopadhyay R., de Belleroche J. Regulation of CCK release in cerebral cortex by N-methyl-d-aspartate receptors: sensitivity to APV, MK-801, kynurenate, magnesium and zinc ions. Neuropeptides 1991, 18:159-163.
4. Bao G., Kang L., Li H., Li Y., Pu L., Xia P., Ma L., Pei G. Morphine and heroin differentially modulate in vivo hippocampal LTP in opiate-dependent rat. Neuropsychopharmacology 2007, 32:1738-1749.
5. Baptista V., Zheng Z.L., Coleman F.H., Rogers R.C., Travagli R.A. Cholecystokinin octapeptide increases spontaneous glutamatergic synaptic transmission to neurons of the nucleus tractus solitarius centralis. J. Neurophysiol. 2005, 94:2763-2771.
6. Breukel A.I., Lopes da Silva F.H., Ghijsen W.E. Cholecystokinin (CCK-8) modulates vesicular release of excitatory amino acids in rat hippocampal nerve endings. Neurosci. Lett. 1997, 234:67-70.
7. Cain D.P., Saucier D., Boon F. Testing hypotheses of spatial learning: the role of NMDA receptors and NMDA-mediated long-term potentiation. Behav. Brain Res. 1997, 84:179-193.
8. Cesselin F. Opioid and anti-opioid peptides. Fundam. Clin. Pharmacol. 1995, 9:409-433.
9. Crawley J.N., Corwin R.L. Biological actions of cholecystokinin. Peptides 1994, 15:731-755.
10. Dauge V., Sebret A., Beslot F., Matsui T., Roques B.P. Behavioral profile of CCK2 receptor-deficient mice. Neuropsychopharmacology 2001, 25:690-698.
11. Drake C.T., Chavkin C., Milner T.A. Opioid systems in the dentate gyrus. Prog. Brain Res. 2007, 163:245-263.
12. Ge J., Long S.K., Kilpatrick I.C. Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365 260, in rat brain. Eur. J. Pharmacol. 1998, 345:163-170.
13. Hadjiivanova C., Belcheva S., Belcheva I. Cholecystokinin and learning and memory processes. Acta Physiol. Pharmacol. Bulg. 2003, 27:83-88.
14. Heinricher M.M., Neubert M.J. Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla. J. Neurophysiol. 2004, 92:1982-1989.
15. Higgins G.A., Nguyen P., Sellers E.M. Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists. Brain Res. 1992, 572:208-215.
16. Holscher C. Synaptic plasticity and learning and memory: LTP and beyond. J. Neurosci. Res. 1999, 58:62-75.
17. Hyman S.E. Addiction: a disease of learning and memory. Am. J. Psych. 2005, 162:1414-1422.
18. Kombian S.B., Ananthalakshmi K.V., Parvathy S.S., Matowe W.C. Cholecystokinin-2 receptors couple to cAMP-protein kinase A to depress excitatory synaptic currents in rat nucleus accumbens in vitro. Can. J. Physiol. Pharm. 2006, 84:203-211.
19. Li S., Ni Z., Cong B., Gao W., Xu S., Wang C., Yao Y., Ma C., Ling Y. CCK-8 inhibits LPS-induced IL-1beta production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-kappaB pathway. Shock 2007, 27:678-686.
20. Lin C.S., Tao P.L., Jong Y.J., Chen W.F., Yang C.H., Huang L.T., Chao C.F., Yang S.N. Prenatal morphine alters the synaptic complex of postsynaptic density 95 with N-methyl-d-aspartate receptor subunit in hippocampal CA1 subregion of rat offspring leading to long-term cognitive deficits. Neuroscience 2009, 158:1326-1337.
21. Ma M.X., Chen Y.M., He J., Zeng T., Wang J.H. Effects of morphine and its withdrawal on Y-maze spatial recognition memory in mice. Neuroscience 2007, 147:1059-1065.
22. Moran T.H., Schwartz G.J. Neurobiology of cholecystokinin. Crit. Rev. Neurobiol. 1994, 9:1-28.
23. Noble F., Roques B.P. Phenotypes of mice with invalidation of cholecystokinin (CCK(1) or CCK(2)) receptors. Neuropeptides 2002, 36:157-170.
24. Peng S., Zhang Y., Zhang J., Wang H., Ren B. Glutamate receptors and signal transduction in learning and memory. Mol. Biol. Rep. 2011, 38:453-460.
25. Salmanzadeh F., Fathollahi Y., Semnanian S., Shafizadeh M. Dependence on morphine impairs the induction of long-term potentiation in the CA1 region of rat hippocampal slices. Brain Res. 2003, 965:108-113.
26. Sanderson D.J., Good M.A., Seeburg P.H., Sprengel R., Rawlins J.N., Bannerman D.M. The role of the GluR-A (GluR1) AMPA receptor subunit in learning and memory. Prog. Brain Res. 2008, 169:159-178.
27. Scuvee-Moreau J. Neurobiology of addiction. Rev. Med. Liege 2013, 68:211-217.
28. Shinohara S., Katsuura G., Eigyo M., Shintaku H., Ibii N., Matsushita A. Inhibitory effect of CCK-8 and ceruletide on glutamate-induced rises in intracellular free calcium concentrations in rat neuron cultures. Brain Res. 1992, 588:223-228.
29. Tramullas M., Martinez-Cue C., Hurle M.A. Chronic administration of heroin to mice produces up-regulation of brain apoptosis-related proteins and impairs spatial learning and memory. Neuropharmacology 2008, 54:640-652.
30. Tronson N.C., Taylor J.R. Addiction: a drug-induced disorder of memory reconsolidation. Curr. Opin. Neurobiol. 2013, 23:573-580.
31. Wang X.J., Fan S.G., Ren M.F., Han J.S. Cholecystokinin-8 suppressed 3H-etorphine binding to rat brain opiate receptors. Life Sci. 1989, 45:117-123.
32. Wang X.J., Han J.S. Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors. J. Neurochem. 1990, 55:1379-1382.
33. Wank S.A. Cholecystokinin receptors. Am. J. Physiol. 1995, 269:G628-G646.
34. Wen D., Cong B., Ma C., Yang S., Yu H., Ni Z., Li S. The effects of exogenous CCK-8 on the acquisition and expression of morphine-induced CPP. Neurosci. Lett. 2012, 510:24-28.
35. Wen D., Ma C.L., Cong B., Yu H.L., Yu F., Ni Z.Y., Li S.J. Interaction of CCK-8 and endogenous opioid system in the opioid dependence. Chin. Pharmacol. Bull. 2010, 26:421-426.
36. Wen D., Zang G., Sun D., Yang S., Yu F., Li S., Ma C., Cong B. Effects of CCK-8 on the reinstatement of morphine-induced CPP and expression of behavioral sensitization in rats. Neuroscience 2013, 238:230-241.
37. Yang S., Wen D., Dong M., Li D., Sun D., Ma C., Cong B. Effects of cholecystokinin-8 on morphine-induced spatial reference memory impairment in mice. Behav. Brain Res. 2013, 256C:346-353.